Vaccines and Related Biological Products Advisory Committee 12, 17, 2020

Views: 4

The U. S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) of a COVID19 vaccine from Moderna, Inc. , COVID19, VRBPAC